ENVISTA HOLDINGS CORP (NVST)
US29415F1049 - Common Stock
Overall NVST gets a fundamental rating of 4 out of 10. We evaluated NVST against 193 industry peers in the Health Care Equipment & Supplies industry. NVST has a medium profitability rating, but doesn't score so well on its financial health evaluation. NVST has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year NVST was profitable.
In the past year NVST had a positive cash flow from operations.
Of the past 5 years NVST 4 years were profitable.
In the past 5 years NVST always reported a positive cash flow from operatings.
1.2 Ratios
NVST has a better Return On Assets (-1.84%) than 66.84% of its industry peers.
Looking at the Return On Equity, with a value of -2.91%, NVST is in the better half of the industry, outperforming 67.88% of the companies in the same industry.
The Return On Invested Capital of NVST (4.41%) is better than 77.20% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NVST is below the industry average of 8.41%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.84% | ||
| ROE | -2.91% | ||
| ROIC | 4.41% |
ROA(3y)2.45%
ROA(5y)2.27%
ROE(3y)3.92%
ROE(5y)3.76%
ROIC(3y)5.53%
ROIC(5y)4.57%
1.3 Margins
NVST has a better Operating Margin (11.84%) than 81.87% of its industry peers.
In the last couple of years the Operating Margin of NVST has grown nicely.
NVST has a Gross Margin (56.35%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of NVST has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.84% | ||
| PM (TTM) | N/A | ||
| GM | 56.35% |
OM growth 3Y16.44%
OM growth 5Y3.83%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.53%
GM growth 5Y0.07%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NVST is destroying value.
NVST has more shares outstanding than it did 1 year ago.
NVST has more shares outstanding than it did 5 years ago.
NVST has a worse debt/assets ratio than last year.
2.2 Solvency
NVST has an Altman-Z score of 1.68. This is a bad value and indicates that NVST is not financially healthy and even has some risk of bankruptcy.
NVST has a Altman-Z score of 1.68. This is comparable to the rest of the industry: NVST outperforms 56.48% of its industry peers.
The Debt to FCF ratio of NVST is 5.77, which is a neutral value as it means it would take NVST, 5.77 years of fcf income to pay off all of its debts.
NVST's Debt to FCF ratio of 5.77 is fine compared to the rest of the industry. NVST outperforms 79.79% of its industry peers.
A Debt/Equity ratio of 0.34 indicates that NVST is not too dependend on debt financing.
NVST has a Debt to Equity ratio of 0.34. This is comparable to the rest of the industry: NVST outperforms 45.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.34 | ||
| Debt/FCF | 5.77 | ||
| Altman-Z | 1.68 |
ROIC/WACC0.49
WACC9.07%
2.3 Liquidity
A Current Ratio of 2.27 indicates that NVST has no problem at all paying its short term obligations.
NVST's Current ratio of 2.27 is on the low side compared to the rest of the industry. NVST is outperformed by 69.43% of its industry peers.
A Quick Ratio of 1.93 indicates that NVST should not have too much problems paying its short term obligations.
The Quick ratio of NVST (1.93) is worse than 60.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.27 | ||
| Quick Ratio | 1.93 |
3. Growth
3.1 Past
NVST shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.78%.
Measured over the past years, NVST shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.41% on average per year.
Looking at the last year, NVST shows a decrease in Revenue. The Revenue has decreased by -0.08% in the last year.
NVST shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.04% yearly.
EPS 1Y (TTM)-23.78%
EPS 3Y16.41%
EPS 5YN/A
EPS growth Q2Q-31.58%
Revenue 1Y (TTM)-0.08%
Revenue growth 3Y9.98%
Revenue growth 5Y-2.04%
Revenue growth Q2Q-0.57%
3.2 Future
The Earnings Per Share is expected to grow by 13.46% on average over the next years. This is quite good.
NVST is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.29% yearly.
EPS Next Y-5.54%
EPS Next 2Y3.69%
EPS Next 3Y6.11%
EPS Next 5Y13.46%
Revenue Next Year1.8%
Revenue Next 2Y3.06%
Revenue Next 3Y4.05%
Revenue Next 5Y6.29%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 13.38, NVST is valued correctly.
Based on the Price/Earnings ratio, NVST is valued cheaply inside the industry as 93.78% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 28.53, NVST is valued rather cheaply.
A Price/Forward Earnings ratio of 11.46 indicates a reasonable valuation of NVST.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NVST indicates a rather cheap valuation: NVST is cheaper than 95.34% of the companies listed in the same industry.
NVST is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 20.31, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.38 | ||
| Fwd PE | 11.46 |
4.2 Price Multiples
NVST's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. NVST is cheaper than 95.34% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, NVST is valued cheaper than 94.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.41 | ||
| EV/EBITDA | 8.86 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.69%
EPS Next 3Y6.11%
5. Dividend
5.1 Amount
NVST does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ENVISTA HOLDINGS CORP
NYSE:NVST (5/15/2024, 3:20:02 PM)
After market: 18.86 0 (0%)18.86
-0.31 (-1.62%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.24B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.38 | ||
| Fwd PE | 11.46 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.84% | ||
| ROE | -2.91% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 11.84% | ||
| PM (TTM) | N/A | ||
| GM | 56.35% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.39
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.34 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.27 | ||
| Quick Ratio | 1.93 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-23.78%
EPS 3Y16.41%
EPS 5Y
EPS growth Q2Q
EPS Next Y-5.54%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-0.08%
Revenue growth 3Y9.98%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y